Michael Campbell to Thyroid Neoplasms
This is a "connection" page, showing publications Michael Campbell has written about Thyroid Neoplasms.
Connection Strength
2.594
-
Woods AL, Li Y, Keegan TH, Nu?o M, Graves CE, Campbell MJ. Incidence and Characteristics of Patients Readmitted for Hypoparathyroidism After Thyroidectomy for Differentiated Thyroid Cancer in California. World J Surg. 2025 Aug; 49(8):2187-2194.
Score: 0.851
-
Woods AL, Li Y, Keegan TH, Nu?o M, Graves CE, Campbell MJ. Hypoparathyroidism After Total Thyroidectomy: A Population-Based Analysis of California Databases. J Surg Res. 2025 06; 310:268-274.
Score: 0.842
-
Haddad RI, Bischoff L, Applewhite M, Bernet V, Blomain E, Brito M, Busaidy NL, Campbell M, DeLozier O, Duh QY, Ehya H, Grady E, Guo T, Haymart M, Hunt JP, Kandeel F, Kotwal A, Lamonica DM, Lorch J, Mandel SJ, Markovina S, Mydlarz W, Nabell L, Raeburn CD, Rezaee R, Ridge JA, Ritter H, Roth MY, Salgado SA, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wirth LJ, Wong RJ, Worden F, Yeh MW, Darlow S, Cassara CJ, Sliker B. NCCN Guidelines? Insights: Thyroid Carcinoma, Version 1.2025. J Natl Compr Canc Netw. 2025 07; 23(7).
Score: 0.213
-
Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS, Guo T, Haymart M, Holt S, Hunt JP, Iagaru A, Kandeel F, Lamonica DM, Mandel S, Markovina S, McIver B, Raeburn CD, Rezaee R, Ridge JA, Roth MY, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Yeh M, Cassara CJ, Darlow S. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 08; 20(8):925-951.
Score: 0.174
-
Graves CE, Goyal N, Levin A, Nu?o MA, Kim J, Campbell MJ, Shen WT, Gosnell JE, Roman SA, Sosa JA, Duh QY, Suh I. Anxiety During the COVID-19 Pandemic: A Web-Based Survey of Thyroid Cancer Survivors. Endocr Pract. 2022 Apr; 28(4):405-413.
Score: 0.167
-
Ames E, Campbell MJ, Afify A, Krane JF, Huang EC. Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroid. Diagn Cytopathol. 2018 Jul; 46(7):632-635.
Score: 0.128
-
Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, G?nen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer. Thyroid. 2016 Mar; 26(3):373-80.
Score: 0.111
-
Ganly I, Nixon IJ, Wang LY, Palmer FL, Migliacci JC, Aniss A, Sywak M, Eskander AE, Freeman JL, Campbell MJ, Shen WT, Vaisman F, Momesso D, Corbo R, Vaisman M, Shaha A, Tuttle RM, Shah JP, Patel SG. Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It? Thyroid. 2015 Oct; 25(10):1106-14.
Score: 0.107